GynTools
Jerusalem
About GynTools
Gyntools was founded in order to provide a comprehensive remote diagnosis solution for vaginitis, the cause for 30% of worldwide gynecology clinic visits. Today, there is not a single comprehensive diagnostic tool that can diagnose all six major conditions to vaginitis, hence, 50% of first clinic visits end with wrong diagnosis which leads to wrong treatment, repeated visits, health complication, continuous suffering for the patients and huge redundant expenses to payers. The system developed by Gyntools, Gyni , is a point of care scanner that, together with a dedicated discharge collection disposables and a cloud based, deep learning algorithm, remotely diagnose correctly (95%) all six major vaginitis conditions, infectious and non- infectious, within five minutes. Gyni is the first automated diagnostic system that diagnose non- infectious vaginitis conditions and is aimed to help doctors better understand their patients’ condition and make more personalized and effective treatment decisions. Gyni enables laboratory quality results in a cost effective manner and requires only web communication and five minutes of waiting.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Grant (Jun 2024)
- Website: gyntools.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device, mHealth
Social Profiles
Canonical: https://fsome.com/organization/gyntools-60696 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.